Join the fight against respiratory syncytial virus (RSV)
RSV research studies are now enrolling
Those who qualify may receive*:
- Payment of up to $440
- Study-related care from local doctors at no cost
- Study medication at no cost
- Compensation for time and travel
- Compensation for time and travel
There is no obligation, so see if you may qualify now.
See if you qualify
Frequently Asked Questions
What is a clinical research study?
A clinical trial, also called a clinical research study, is a carefully designed scientific evaluation of an investigational medicine or treatment. Clinical trials are conducted by doctors and researchers. Clinical research helps doctors and scientists determine if an investigational medicine or therapies are safe and/or effective for use in humans to potentially treat a condition, disease, or disorder.
Before regulatory authorities that are responsible for approving medicines for use in each country can consider an investigational medicine, device, or procedure for approval, it must be shown to be both safe and work well, or the overall benefits outweigh the risks. Typically, this is accomplished through clinical trials.
Clinical trials must be reviewed by an Institutional Review Board (IRB) or Ethics Committee (EC). An IRB or EC is a group that is responsible for helping to protect the rights and welfare of study participants. In addition, every study participant is monitored with medical tests and study-related exams before, during, and sometimes even after the trial.
What happens if I sign up?
If you are interested in participating, please fill out the online questionnaire below to see if you are eligible for the study. If you are potentially eligible, we will match you to a clinical research site in your area that is participating in the Auτonomy Study and seeking participants. Someone from the clinical research site will contact you to explain more about the study and to determine if you meet the study criteria before you make your decision about participating. The site team will provide you with more details about the study and determine your next steps.
About the [Condition] Study
Who can take part?
About the [Condition] Study
Our heart disease research studies, also called clinical trials, are looking at how safe investigational medications are for different heart diseases. Heart disease clinical trials can include people with:
- cardiovascular risk and diabetes
- very high cholesterol and triglycerides
- atrial fibrillation (AFib)
- stroke
People can only receive investigational medications as part of clinical research studies. Investigational medications are not yet approved by health authorities. Some people participate in research studies to contribute to medical science and help doctors find other ways to help patients.
How does it work ?
1
2
3
4
5
How does it work?
What to expect?
During the treatment period, you will receive the investigational study drug (the investigational medicine or a placebo) once every month. The study drug will be given by a slow injection into a vein (“intravenous” or “IV infusion”). The investigational medicine will be compared with a placebo. A placebo looks just like the investigational medicine and is given in the same way, but it does not contain any active ingredients. Neither you, your study partner, nor the study team will know which study drug you will receive during the study. There is a 2-in-3 chance of receiving the investigational medicine and a 1-in-3 chance of receiving the placebo.
Several tests and assessments will be performed to monitor your health. These will include:
